Amniotic fluid-derived stem cells (AFSCs) are a potential cell source for therapeutic
applications. They can be easily mass produced, cryopreserved and shipped to clinics for …

Amniotic fluid (AF) was described as a potential source of mesenchymal stem cells (MSCs)
for biomedicine purposes. Therefore, evaluation of alternative cryoprotectants and freezing …

Abstract Objectives Stem cells (SCs) can be isolated from amniotic fluid (AF) for a variety of
perinatal applications. In view of this, we compared different cryopreservation protocols for …

Background The therapeutic use of human embryonic stem cells (hESCs) is dependent on
an efficient cryopreservation protocol for long-term storage. The aim of this study was to …

The development of efficient and robust methods for the cryopreservation of human
embryonic stem cells (hESCs) is important for the production of master and working cell …

Background Amnion-derived stem cells have been proposed for cell replacement therapy
and tissue regeneration. An easily accessible cell source, the placenta, allows us to …

Human amniotic fluid stem cells (hAFSCs) have features intermediate between embryonic
and adult SCs, can differentiate into lineages of all three germ layers, and do not develop …

Cryopreservation of umbilical cord blood-derived mesenchymal stem cells (UCB-derived
MSCs) is crucial step for its clinical applications in cell transplantation therapy. In the …

Despite a vast amount of different methods, protocols and cryoprotective agents (CPA), stem
cells are often frozen using standard protocols that have been optimized for use with cell …

BACKGROUND: Human amniotic-derived mesenchymal stromal cells (hAMSC) are a novel
population of multipotent stem cells that have been shown to have great potential for use in …